It typically exhibits resistance to multiple antibiotics with newer fluroquinolones, trimethoprim-sulfamethoxazole, and rifampin shows some sensitivity.[ 6 ] There is an increasing trend of C. indologenes infections after rise in colistin and tigecycline usage.[ 7 ] There are no established recommendations for the management of C. indologenes infections.
← all excerpts
Severe Sepsis Due to <i>Chryseobacterium indologenes</i>, a Possible Emergent Multidrug-Resistant Organism in Intensive Care Unit-Acquired Infections.
1
—
—